general

Microsoft joins World Nuclear Association as it doubles down on small modular reactors and fusion energy

Efosa Udinmwen

<ul><li>Microsoft is chasing carbon-free energy while data demand keeps rising</li><li>The World Nuclear Association gains unprecedented visibility through Microsofts membership</li><li>Small modula ...[Continue Reading]

TechRadar

1 day ago

Recent News (General)

general

Cheap imports or strong industry: the EU steel trade measure will decide [Promoted content]

Axel Eggert

U.S. tariffs, EU vulnerability The United States has imposed prohibitive 50% tariffs on steel and its derivatives, shutting European producers out of its major export market. Despite months of negot ...[Continue Reading]

EURACTIV

1 day ago

general

Agent Has No Duty to Tell Insured of Pending Nonrenewal: Connecticut High Court

Andrew G. Simpson

A Connecticut insurance agent has no duty to inform clients that their home insurer intends not to renew their insurance policy, the states high court recently affirmed in a case where the homeowner ...[Continue Reading]

Insurance Journal

1 day ago


general

Leaving post, but not leaving Ireland, the UK ambassador who is not going home

Mark Hennessy

Sitting in the quad of an Oxford college, Paul Johnston, the outgoing British ambassador to Ireland who leaves his post in less than a fortnight, talks about here, though he refers not to the English ...[Continue Reading]

The Irish Times

1 day ago


general

'Most nations are starting to talk about space as a domain of warfare'

Niki Seth-Smith

Security expert Mark Hilborne talks to us about space warfare - and how it could be the deciding factor in the Russia-Ukraine conflict Mark Hilborne leads the space security group at Kings College L ...[Continue Reading]

Newhumanist.org.uk

1 day ago


general

Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)

Novartis Pharma AG

<ul><li>Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular disease</li><li>Pacibekitug is ...[Continue Reading]

GlobeNewswire

1 day ago